Clinical trial
Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
NCT00326287 · Basilea Pharmaceutica, Industry · Completed
Key facts
| NCT number | NCT00326287 |
|---|---|
| Title | Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia |
| Official title | A Randomized, Double-Blind, Multicenter Study of Ceftobiprole Medocaril Versus Placebo in the Treatment of Subjects Hospitalized With Community-Acquired Pneumonia |
| Lead sponsor | Basilea Pharmaceutica, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Drug |
| Interventions | Ceftobiprole medocaril, Ceftriaxone with or without Linezolid |
| Enrollment | 638 |
| Start date | Jun 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | May 16, 2006 |
| Last update posted | Aug 2, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: